A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress

Clinical trial NCT06658535 · RECRUITING

Trial details

NCT number: NCT06658535
Sponsor: NuvOx LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Respiratory Distress

Start date: 2025-03-13
Primary completion: 2026-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.